1. Home
  2. LSE vs FLNA Comparison

LSE vs FLNA Comparison

Compare LSE & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leishen Energy Holding Co. Ltd. Ordinary Shares

LSE

Leishen Energy Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$4.11

Market Cap

74.4M

Sector

Industrials

ML Signal

N/A

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$1.24

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LSE
FLNA
Founded
2007
1998
Country
China
United States
Employees
N/A
20
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
61.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LSE
FLNA
Price
$4.11
$1.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.2K
357.0K
Earning Date
01-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$61.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$1.16
52 Week High
$7.40
$2.03

Technical Indicators

Market Signals
Indicator
LSE
FLNA
Relative Strength Index (RSI) 43.41 40.38
Support Level N/A $1.16
Resistance Level $5.35 $1.80
Average True Range (ATR) 0.76 0.09
MACD 0.01 -0.01
Stochastic Oscillator 19.31 16.28

Price Performance

Historical Comparison
LSE
FLNA

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: